🇺🇸 FDA
Patent

US 6696601

Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

expired A61PA61P19/00A61P19/08

Quick answer

US patent 6696601 (Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61P, A61P19/00, A61P19/08, A61P19/10